IMS Health, the leading provider of information, services and technology for the global healthcare industry. Whether you require data for benchmarking, competition analysis or simply to find out what new intellectual properties are being licensed, IMS Health gives you access to the latest intelligence for the pharmaceutical and biotech field.
...step to those unfamiliar to dealmaking. The report discusses in detail all aspects of partnering including the steps that are involved from identifying the opportunity through to negotiating and signing the deal and beyond; the ... Read More
...aspect in the deal negotiation. The Guide to Valuation of Pharmaceutical Licensing Deals Report provides insight and solutions to the challenges faced by deal-makers in the biopharmaceutical industry when valuing projects at various development stages. Read More
...Assessment of Valuation in the Pharmaceutical Sector is the definitive guide for the industry and provides in-depth analysis of one of the most important but elusive components of a biopharma deal – the royalty rate. Read More
...lucrative sector of diabetes. Data and analysis presented in the report is based on the IMS PharmaDeals database, the leading source of deals and alliances information in the life science industry. Use this report to: ... Read More
...industry deal-makers who share their thoughts on royalty rates Receive guidance on the best methodologies to use including benchmarking and expected net present value when calculating royalty rates for vital decision making Understand the differences ... Read More